Search results

Black Diamond Therapeutics BDTX is a clinical-stage oncology company with an investment story that largely runs through a single program: silevertinib, its brain-penetrant, fourth-generation

Veralto VLTO is set to report its first-quarter 2026 results on April 28, after the closing bell.

The company’s earnings surprise history has been impressive. It surpassed the Zacks Consensus

Flexsteel Industries (FLXS) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might

Shares of Peoples Bancorp of North Carolina, Inc. PEBK have lost 6.2% since the company reported its earnings for the quarter ended March 31, 2026, underperforming the S&P 500 Index, which gained

As Molson Coors Beverage Company TAP prepares to unveil its first-quarter fiscal 2026 earnings on April 30, before market open, investors are eager to see if the company can beat market

Stereotaxis STXS has announced the first successful U.S. procedures using its MAGiC robotic magnetic ablation catheter, following recent approval from the FDA. The milestone highlights the company’s

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

United Airlines UAL reported solid first-quarter 2026 results on April 21, with both earnings and revenues surpassing expectations and improving year over year. Adjusted earnings per share (EPS) of

The Allstate Corporation ALL is set to report its first-quarter 2026 results on April 29, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently

DigitalOcean DOCN sits in a favorable demand backdrop as artificial intelligence (AI) inference remains supply-constrained, but the investment case hinges on execution and timing. DOCN shares are

CBRE Group, Inc. CBRE posted first-quarter 2026 core earnings of $1.61 per share, up 80.9% from 89 cents a year ago. The figure beat the Zacks Consensus Estimate of $1.13 by 42.48%.

Quarterly

The companies belonging to Zacks Oil and Gas-Integrated-United States industry present a strong long-term investment case, supported by abundant shale resources, advanced extraction technologies and

Cisco Systems CSCO is witnessing a sharp acceleration in AI-related demand, especially from hyperscalers. AI orders in second-quarter fiscal 2026 increased to $2.1 billion from $1.3 billion in

Earnings growth is essential for any organization, regardless of size, because profitability determines long-term survival. Earnings are calculated by subtracting the cost of producing goods and

Investors in American Healthcare REIT, Inc. AHR need to pay close attention to the stock based on moves in the options market lately. That is because the July 17, 2026 $25 Call had some of the

Investors in AH REALTY TRUST INC AHRT need to pay close attention to the stock based on moves in the options market lately. That is because the May 15, 2026 $25 Call had some of the highest implied

World Kinect (WKC) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.48 per share a year ago. These

WSFS Financial (WSFS) came out with quarterly earnings of $1.45 per share, missing the Zacks Consensus Estimate of $1.48 per share. This compares to earnings of $1.13 per share a year ago. These